Locations:
SearchResearch Finds TMAO – A Gut Byproduct of Animal-Rich Diets – Encourages Over-Reactive Platelet Function, Increasing Thrombosis Risk
Cleveland Clinic News Service | 216.444.0141
We’re available to shoot custom interviews & b-roll for media outlets upon request.
CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.
images: 0
video: 0
audio: 0
text: 0
In a combination of both clinical studies of over 4,000 patients and animal model studies, Cleveland Clinic researchers have demonstrated – for the first time – that gut microbes alter platelet function and risk of blood clot-related illnesses like heart attack and stroke.
When the nutrient choline – which is abundant in animal products like meat and egg yolk – is ingested, gut microbes play a role in breaking it down and producing the compound TMAO. High levels of TMAO have been linked to heart disease in recent studies. The studies showed that blood TMAO levels are associated with heightened risk of heart attacks and strokes in humans, even after adjusting for traditional cardiac risk factors, renal function, markers of inflammation, medication use, and cardiovascular disease status.
The new study – to be published in Cell’s March 10 online edition and March 24 print edition – shows that TMAO directly alters platelet function, increasing thrombosis (blood clot) potential, which could potentially be the mechanism by which TMAO increases heart attack and stroke risk. These findings reveal a previously unrecognized mechanistic link between specific dietary nutrients, gut microbes, platelet function, and thrombosis risk.
“It is remarkable that gut microbes produce a compound that alters platelet function and thrombotic heart attack and stroke risk,” said lead author Stanley Hazen, MD, PhD, chair of the Department of Cellular & Molecular Medicine in the Lerner Research Institute and section head of Preventive Cardiology & Rehabilitation in the Miller Family Heart & Vascular Institute at Cleveland Clinic “This new link helps explain how diet-induced TMAO generation is mechanistically linked to development of lethal adverse complications of heart disease. The results of the studies suggest potential new therapeutic targets and possible nutritional interventions for preventing cardiovascular events and improving heart health.”
This latest discovery further adds to the growing body of data showing a link between TMAO, gut microbes, and heart disease. It also shows that lowering TMAO may represent a potential new way to reduce the formation of blood clots, and therefore decrease the risk of cardiovascular events like heart attacks and strokes. Heart disease is the No. 1 killer in the world of both men and women.
The link between TMAO, gut microbes and heart disease was first discovered five years ago by the same investigative team, led by Dr. Hazen, Weifei Zhu, PhD, and Jill Gregory, PhD are co-first authors on the current manuscript, and are also members in the Department of Cellular & Molecular Medicine in the Lerner Research Institute.
In this study, researchers analyzed blood levels of TMAO in over 4,000 patients and saw a significant correlation between higher TMAO and thrombosis potential. This generated the hypothesis that TMAO may directly impact platelet function. Subsequent studies with both human platelets and animal models confirmed that TMAO makes platelets over-reactive, heightening thrombosis potential and accelerating clotting rates. Enhanced platelet responsiveness and clot formation is the culminating event that causes a heart attack or stroke, which account for the majority of deaths worldwide.
“We have shown that TMAO fundamentally alters calcium signaling within platelets; when TMAO is elevated, platelet responsiveness to known triggers like thrombin, collagen or ADP is heightened,” Hazen said. “In general, there’s a broad range for how quickly different people will form clots. However, across the board, when TMAO is elevated, platelet responsiveness jumps to the hyper-reactive side of normal.”
Microbial transplantation studies showed TMAO production and thrombosis potential are transmissible traits, building on the recent demonstration that atherosclerosis susceptibility similarly can be transmitted from donor to recipient with transfer of gut microbes via TMAO production potential.
According to the Centers for Disease Control and Prevention, heart disease kills about 610,000 in the United States annually, accounting for one in every four deaths.
This research was supported by grants from the National Institutes of Health and the Office of Dietary Supplements.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 82,600 employees worldwide are more than 5,786 salaried physicians and researchers, and 20,700 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,728-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 280 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2024, there were 15.7 million outpatient encounters, 333,000 hospital admissions and observations, and 320,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 112 countries. Visit us at clevelandclinic.org. Follow us at x.com/CleClinicNews. News and resources are available at newsroom.clevelandclinic.org.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
